Novel metabolic surgery for type II diabetes mellitus: Loop duodenojejunal bypass with sleeve gastrectomy

Surgical Laparoscopy, Endoscopy and Percutaneous Techniques

Volumn 23, Issue 6, 2013, Pages 481-485

  Huang, Chih Kun ^a   Goel, Rajat ^a   Tai, Chi Ming ^a   Yen, Yung Chieh ^b   Gohil, Vijayraj D ^a   Chen, Xiao Yan ^a  

^a E DA HOSPITAL   (Taiwan)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

loop duodenojejunal bypass; obesity; sleeve gastrectomy; type 2 diabetes mellitus

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; OPIATE; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; BODY MASS; CLINICAL ARTICLE; DISEASE DURATION; FASTING PLASMA GLUCOSE; FEMALE; FOLLOW UP; GASTROINTESTINAL REFLUX; GASTROINTESTINAL STAPLER; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INTERMETHOD COMPARISON; INTESTINE SURGERY; LAPAROSCOPIC SCALPEL; LOOP DUODENOJEJUNAL BYPASS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REMISSION; REVIEW; SLEEVE GASTRECTOMY; VOMITING;

ADULT; BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; DUODENUM; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; JEJUNUM; MALE; MIDDLE AGED; POSTOPERATIVE CARE; TREATMENT OUTCOME;

EID: 84890664686     PISSN: 15304515     EISSN: 15344908     Source Type: Journal    
DOI: 10.1097/SLE.0b013e3182950111     Document Type: Review

References (30)

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimate for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
2. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery; a systematic review and meta-analysis. JAMA. 2004;292:1724-1737.
3. Buchwald H, Oien DM. Metabolic/bariatric surgery Worldwide 2008. Obes Surg. 2009;19:1605-1611.
4. Brancatisano A, Wahlroos S, Brancatisano R. Improvement in comorbid illness after placement of the Swedish Adjustable Gastric Band. Surg Obes Relat Dis. 2008;4:S39-S46.
5. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and metaanalysis. Am J Med. 2009;122:248-256.
6. Hussain A, Mahmood H, El-Hasani S. Can Roux-en-Y gastric bypass provide a lifelong solution for diabetes mellitus? Can J Surg. 2009;52:E269-E275.
7. Huang CK, Shabbir A, Lo CH, et al. Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25-35. Obes Surg. 2011;21:1344-1349.
8. Scopinaro N, Adami GF, Papadia FS, et al. Effects of biliopancreatic diversion on type 2 diabetes in patients with BMI 25 to 35. Ann Surg. 2011;253:699-703.
9. Lee WJ, Chong K, Chen CY, et al. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2. Obes Surg. 2011;21:889-895.
10. Ramos A, Galvão M, de Souza Y, et al. Laparoscopic duodenal-jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI <30 kg/m2 (LBMI). Obes Surg. 2009;19:307-312.
11. Ferzli GS, Dominique E, Ciaglia M, et al. Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis. World J Surg. 2009;33:972-979.
12. Fried M, Ribaric J, Buchwald J, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies. Obes Surg. 2010;20:776-790.
13. Mari A, Manco M, Guidone C, et al. Restoration of normal glucose tolerance in severely obese patients after biliopancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia. 2006;49:2136-2143.
14. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, et al. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes. 2003;52:1098-1103.
15. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741-749.
16. Gault VA, Irwin N, Green BD, et al. Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3) GIP administration improves glucose tolerance and ameliorates insulin resistance and abnormalities of islet structure in obesity related diabetes. Diabetes. 2005;54:2436-2446.
17. Zhou H, Yamada Y, Tsukiyama K, et al. Gastric inhibitory polypeptide modulates adiposity and fat oxidation under diminished insulin action. Biochem Biophys Res Commun. 2005;335:937-942.
18. Bedno S. Weight loss in diabetes management. Nutr Clin Care. 2003;6:62-72.
19. Swinburn B. Effects of dietary lipid on insulin action. Ann N Y Acad Sci. 1993;683:102-109.
20. Pilichiewicz AN, Chaikomin R, Brennan IM, et al. Loaddependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men. Am J Physiol Endocrinol Metab. 2007; 293:e743-e753.
21. Bagger JI, Knop FK, Lund A, et al. Impaired regulation of the incretin effect in patients with type 2 diabetes. J Clin Endocrinol Metab. 2011;96:737-745.
22. Kasama K, Tagaya N, Kanehira E, et al. Laparoscopic sleeve gastrectomy with duodenojejunal bypass: technique and preliminary results. Obes Surg. 2009;19:1341-1345.
23. Higa KD, Boone KB, Ho T. Complications of the laparoscopic Roux-en-Y gastric bypass: 1040 patients. What have we learned? Obes Surg. 2000;10:509-513.
24. Langer FB, Reza MA, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024-1029.
25. Vidal J, Ibarzabal A, Nicolau J, et al. Short-term effects on sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects. Obes Surg. 2007;17:1069-1074.
26. De Paula AL, Macedo AL, Prudente AS, et al. Laparoscopic sleeve gastrectomy with ileal interposition ("neuroendocrine break")-pilot study of a new operation. Surg Obes Relat Dis. 2006;2:464-467.
27. Kao YH, Lo CH, Huang CK. Relationship of bypassed limb length and remission of type 2 diabetes mellitus after Rouxen-Y gastric bypass. Surg Obes Relat Dis. 2012;8:e82-e84.
28. Lee WJ, Wang W, Lee YC, et al. Laparoscopic mini-gastric bypass: experience with tailored bypass limb according to body weight. Obes Surg. 2008;18:294-299.
29. Karamanakos SN, Vagenas K, Kalfarentzos F, et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy. A prospective, double blind study. Ann Surg. 2008;247:401-407.
30. Shikora SA, Kim JJ, Tarnoff ME. Nutrition and gastrointestinal complications of bariatric surgery. Nutr Clin Pract. 2007;22:29-40.